List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 32 studies with search of: "Dengue"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus
Interventions: Biological: Chimeric dengue serotype (1, 2, 3, 4);   Biological: Chimeric dengue serotype (1, 2, 3, 4);   Biological: Chimeric dengue serotype (1, 2, 3, 4)
2 Recruiting Efficacy and Safety of Dengue Vaccine in Healthy Children
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric tetravalent dengue (serotype 1, 2, 3, 4);   Biological: Inactivated Rabies virus vaccine
3 Recruiting Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Disease
Interventions: Biological: Chimeric dengue serotypes (1, 2, 3, 4).;   Biological: Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
4 Recruiting Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus;   Dengue Diseases
Interventions: Biological: CYD Dengue vaccine;   Biological: NaCl + influenza virus or hepatitis A vaccine
5 Active, not recruiting Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Chimeric dengue serotype 1, 2, 3, and 4;   Biological: Pneumococcal polysaccharide vaccine
6 Active, not recruiting Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults
Conditions: Dengue Virus;   Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Diseases
Interventions: Biological: Bivalent CYD-1,3 Dengue (Vero);   Biological: Bivalent CYD-2,4 Dengue (Vero);   Biological: Tetravalent blending VDV-2/CYD-1,3,4 Dengue (Vero);   Biological: Tetravalent CYD-1,2,3,4 Dengue (Vero);   Biological: Japanese encephalitis virus vaccine inactivated
7 Recruiting A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Shock Syndrome
Intervention: Biological: Tetravalent live attenuated dengue vaccine
8 Active, not recruiting Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue Virus
Interventions: Biological: ChimeriVax™ Tetravalent Dengue Vaccine;   Biological: ChimeriVax™ Tetravalent Dengue Vaccine;   Biological: ChimeriVax™ Tetravalent Dengue Vaccine
9 Completed Follow-Up Study of Thai Children From Dengue-003 and Evaluation of a Booster Dose of Dengue Vaccine
Condition: Dengue
Interventions: Biological: Live attenuated tetravalent dengue (DEN) vaccine;   Biological: Formulation 17
10 Recruiting Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
Condition: Dengue Hemorrhagic Fever
Interventions: Biological: rDEN1delta30;   Biological: rDEN2/4delta30(ME);   Biological: Placebo to rDEN1delta30 or rDEN2/4delta30(ME)
11 Recruiting Safety of and Immune Response of a 2-Dose Regimen of rDEN1delta30 Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: rDEN1delta30;   Biological: Placebo
12 Active, not recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-4995) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN4delta30-4995;   Biological: Placebo
13 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
Condition: Dengue
Interventions: Biological: rDEN3/4delta30(ME);   Biological: Placebo
14 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN1delta30;   Biological: Placebo
15 Recruiting Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
16 Recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN4delta30-200,201;   Biological: Placebo
17 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN2/4delta30(ME) Vaccine;   Biological: Placebo
18 Not yet recruiting Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
19 Active, not recruiting Safety Study of a Dengue Virus DNA Vaccine
Condition: Dengue
Intervention: Biological: D1ME (dengue-1 premembrane/envelope DNA vaccine)
20 Completed A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children
Conditions: Dengue;   Vaccine
Intervention: Biological: Dengue vaccine

Previous Page Studies Shown (1-20) Next Page (21-32)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services